Mariana Dvoroznakova

Dr. Mariana Dvoroznakova


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
PFPavol Fülöp
Pavol Fülöp
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
ZFZuzana Fülöpová
Zuzana Fülöpová
ABAnna Borovská
Anna Borovská
MDMariana Dvoroznakova
Mariana Dvoroznakova
Background: Despite the availability of direct oral anticoagulants, warfarin remains essential for mechanical valves, renal impairment, and resource-limited settings. Traditional dosing achieves therapeutic range in only 55–65% of patients, increasing bleeding and thrombotic complications. This systematic review evaluates the literature on machine learning (ML) approaches for warfarin dose prediction (2022–2025). Methods: We analysed 14 studies encompassing 122,400 patients across nine countries following PRISMA guidelines. Studies utilizing ML algorithms for warfarin dosing with quantifiable performance metrics were included. Risk of bias was assessed using PROBAST. Results: Reinforcement learning demonstrated superior performance, achieving an 80.8% excellent responder ratio versus 41.6% for standard practice and 99.5% safety responder ratio versus 83.1%. Support vector machines achieved R2 up to 0.98 in homogeneous populations. Mean absolute error ranged from 0.11 to 1.8 mg/day, consistently outperforming traditional methods. Seven studies included external validation, whilst 78.6% were retrospective designs. Limited implementation studies showed therapeutic INR rates improving from 47.5% to 61.1%. Critically, only three studies (21.4%) reported any safety outcomes, with none adequately powered to detect differences in major bleeding events. Conclusions: While ML algorithms demonstrate improved dosing accuracy in retrospective analyses, the near-complete absence of adequately powered safety outcome data represents the primary barrier to clinical implementation. Without robust evidence on bleeding, thromboembolism, and mortality, the risk–benefit profile remains unknown. Implementation requires addressing: the predominance of retrospective studies (78.6%), limited prospective validation, restricted geographic diversity (43% from China), absence of African and South American studies, and no new Hispanic population data. Multicentre prospective trials with safety endpoints, population-specific validation, and interpretable models are essential before widespread clinical adoption can be recommended.

1 January 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
ŠTŠtefan Tóth
Štefan Tóth
MVMarianna Vachalcova
Marianna Vachalcova
KBKamil Barbierik
Kamil Barbierik
AJAdriana Jarolimkova
Adriana Jarolimkova
PFPavol Fülöp
Pavol Fülöp
TPTibor Poruban
Tibor Poruban
Background/Objectives: Cardiovascular (CV) diseases remain the leading cause of morbidity and mortality across Europe. Despite substantial progress in prevention, diagnostics, and therapeutics, outpatient cardiology care continues to face systemic challenges, including limited consultation time, workforce constraints, and incomplete clinical information at the point of care. The primary objective of this study is threefold. First, to evaluate whether AI-enhanced telemedicine improves clinical control of hypertension, dyslipidemia, and heart failure compared to standard ambulatory care. Second, to assess the impact on physician workflow efficiency and documentation burden through AI-assisted clinical documentation. Third, to determine patient satisfaction and safety profiles of integrated telemedicine–AI systems. Clinical control will be measured by a composite endpoint of disease-specific targets assessed at the 12-month follow-up visit. Methods: The TeleAI-CVD Concept Study aims to evaluate the integration of telemedicine and artificial intelligence (AI) to enhance the efficiency, quality, and individualization of cardiovascular disease management in the ambulatory setting. Within this framework, AI-driven tools will be employed to collect structured clinical histories and current symptomatology from patients prior to outpatient visits using digital questionnaires and conversational interfaces. Results: Obtained data, combined with telemonitoring metrics, laboratory parameters, and existing clinical records, will be synthesized to support clinical decision-making. Conclusions: This approach is expected to streamline consultations, increase diagnostic accuracy, and enable personalized, data-driven care through continuous evaluation of patient trajectories. The anticipated outcomes of the TeleAI-CVD study include the development of optimized, AI-assisted management protocols for cardiology patients, a reduction in unnecessary in-person visits through effective telemedicine-based follow-up, and accelerated attainment of therapeutic targets. Ultimately, this concept seeks to redefine the paradigm of outpatient cardiovascular care by embedding advanced digital technologies within routine clinical workflows.

27 November 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
ABAlžbeta Bánovčinová
Alžbeta Bánovčinová
ISIngrid Schusterova
Ingrid Schusterova
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
DPDominik Pella
Dominik Pella
PFPavol Fülöp
Pavol Fülöp
Background: Childhood obesity demonstrates substantial metabolic heterogeneity. We determined insulin resistance prevalence in Slovak children with obesity using multiple validated markers and identified high-risk phenotypes. Methods: Cross-sectional study of 54 obese children (BMI 29.5 ± 4.7 kg/m2) and 33 controls (BMI 20.6 ± 1.9 kg/m2). All underwent bioelectrical impedance analysis and fasting metabolic profiling, including HOMA-IR and triglyceride-to-HDL cholesterol (TG/HDL-C) ratio. Insulin resistance was defined as HOMA-IR > 3.42 (obese) or >1.68 (controls), and TG/HDL-C > 0.99 mmol/L. Age-matched sensitivity analysis was performed on 28 pairs. Results: Among obese children, 44.4% demonstrated HOMA-IR-defined insulin resistance versus 45.5% of controls using respective cut-offs, with significantly higher mean HOMA-IR (3.66 ± 2.09 vs. 2.53 ± 2.59, p = 0.034). Age-matched analysis (n = 28 pairs, mean age difference 0.22 years) confirmed these findings with HOMA-IR 3.46 ± 2.18 vs. 2.27 ± 2.22 (p = 0.0271). The TG/HDL-C ratio identified insulin resistance in 38.9% of obese versus 12.1% of controls. Critically, 22.2% of obese children showed concordant elevation of both markers (vs. 6.1% controls; OR 4.43); in age-matched analysis, this difference was even more pronounced (17.9% vs. 3.6%). Low skeletal muscle mass (40%) characterized 22.6% of obese children, demonstrating 91.7% insulin resistance prevalence versus 31.0% without low muscle mass (p < 0.001), with HOMA-IR 1.9 points higher (95% CI: 0.31–2.73). Remarkably, 50% of children with low muscle mass showed concordant elevation of both metabolic markers versus 14.3% without (OR 6.0). Conclusions: Low skeletal muscle mass in obese Slovak children represents a very-high-risk phenotype with 91.7% insulin resistance prevalence and 6-fold increased odds of severe metabolic dysfunction. Age-matched analysis confirmed that metabolic differences are independent of age effects. Body composition-based risk stratification enables personalized interventions targeting the highest-risk children.

14 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
KUKarolina Angela Sieradzka Uchnar
Karolina Angela Sieradzka Uchnar
ISIngrid Schusterova
Ingrid Schusterova
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
MDMariana Dvoroznakova
Mariana Dvoroznakova
PFPavol Fülöp
Pavol Fülöp
Objective: This study aims to analyze relationships between body composition, biochemical parameters, and cardiac function in young adults to identify mechanisms of cardiac dysfunction in obesity. Methods: This is a cross-sectional study of 60 young adults (mean age 20.4 years) divided into healthy (n = 29) and overweight/obese (n = 31) groups. Body composition was assessed using bioelectrical impedance analysis. We calculated the SMM-to-Fat ratio (skeletal muscle mass %/body fat %) as a continuous composite metric. Cardiac function was evaluated using 3D speckle-tracking echocardiography, with a 3D global circumferential strain pre-specified as the primary endpoint. Results: The obese group showed unfavorable body composition with lower SMM% (38.0 ± 10.8 vs. 47.1 ± 5.6%), higher body fat% (28.3 ± 12.6 vs. 16.0 ± 8.3%), and lower SMM-to-Fat ratio (2.1 ± 2.3 vs. 4.8 ± 5.1; all p < 0.001). C-peptide was 75% higher (p < 0.001), indicating compensatory hyperinsulinemia. The primary endpoint showed impairment in the obese group (−19.8 ± 4.7 vs. −22.2 ± 2.9%; p = 0.023, d = 0.61), while longitudinal strain was preserved, indicating selective mid-wall dysfunction. The SMM-to-Fat ratio demonstrated a stronger association with circumferential strain (r = −0.467, p = 0.008) than SMM% alone (r = −0.414, p = 0.021) and remained an independent predictor in multivariable analysis (β = −0.88, p = 0.019), whereas SMM% did not achieve significance (p = 0.159). Comprehensive analysis revealed correlation reversal across all body composition parameters between groups, with minerals% and total body water% emerging as additional independent predictors. Conclusions: Young obese adults exhibit selective mid-wall cardiac dysfunction. The SMM-to-Fat ratio, representing muscle–adiposity balance, is superior to SMM% alone for predicting cardiac dysfunction. Our findings suggest that the relative balance, rather than absolute muscle mass, determines cardiac health in obesity, with implications for body composition assessment and intervention strategies.

30 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ABAlzbeta Banovcinova
Alzbeta Banovcinova
ISIngrid Schusterova
Ingrid Schusterova
ŠTŠtefan Tóth
Štefan Tóth
TPTibor Poruban
Tibor Poruban
DPDominik Pella
Dominik Pella
PFPavol Fülöp
Pavol Fülöp
Background: Childhood obesity demonstrates substantial metabolic heterogeneity. We determined insulin resistance prevalence in Slovak children with obesity using multiple validated markers and identified high-risk phenotypes. Methods: Cross-sectional study of 54 obese children (BMI 29.5±4.7 kg/m²) and 33 controls (BMI 20.6±1.9 kg/m²). All underwent bioelectrical impedance analysis and fasting metabolic profiling including HOMA-IR and triglyceride-to-HDL cholesterol (TG/HDL-C) ratio. Insulin resistance was defined as HOMA-IR >3.42 (obese) or >1.68 (controls), and TG/HDL-C >0.99 mmol/L. Age-matched sensitivity analysis was performed on 30 pairs. Results: Among obese children, 44.4% demonstrated HOMA-IR-defined insulin resistance versus 51.7% of controls using respective cut-offs, with significantly higher mean HOMA-IR (3.66±2.07 vs 2.53±2.55, p40%) characterized 24.1% of obese children, demonstrating 85.7% insulin resistance prevalence versus 30.0% without low muscle mass (p< 0.01), with HOMA-IR 1.52 points higher (95% CI: 0.31-2.73). Remarkably, 42.9% of children with low muscle mass showed concordant elevation of both metabolic markers versus 15.0% without (OR 4.25). Conclusions: Low skeletal muscle mass in obese Slovak children represents an ultra-high-risk phenotype with 85.7% insulin resistance prevalence and 4.25-fold increased odds of severe metabolic dysfunction. Age-matched analysis confirmed that metabolic differences are independent of age effects. Body composition-based risk stratification enables personalized interventions targeting the highest-risk children.

9 March 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
PFPavol Fülöp
Pavol Fülöp
Zuzana PellaZuzana Pella
Zuzana Pella
TPTibor Poruban
Tibor Poruban
PHPeter Hreško
Peter Hreško
FZFrantišek Pavol Zajac
František Pavol Zajac
DPDominik Pella
Dominik Pella
Background: The relationship between testosterone and coronary artery disease (CAD) remains a subject of debate. Most studies suggest an inverse association—lower testosterone, higher risk. However, data from Central European populations undergoing coronary angiography are limited. Objectives: To investigate the association between serum testosterone levels and angiographically confirmed coronary artery stenosis in a Slovak population. Methods: This cross-sectional study included 129 consecutive stable patients (84 men, 45 women; mean age 64.3 ± 9.7 years) undergoing elective coronary angiography for suspected stable coronary artery disease. Significant coronary stenosis was defined as ≥50% luminal narrowing in any major epicardial vessel. Serum testosterone, lipid profile, and traditional risk factors were assessed. Univariate and multivariate logistic regression models were constructed to evaluate independent associations of coronary stenosis. Results: Coronary stenosis ≥ 50% was present in 74 patients (57.4%). Notably, patients with stenosis had significantly higher testosterone levels (6.62 ± 2.79 vs. 4.85 ± 3.50 ng/mL, p = 0.002). In univariate analysis, testosterone showed a significant association (OR 1.197 per ng/mL, OR 1.784 per SD, p = 0.003). In multivariate analysis adjusted for age, sex, diabetes mellitus, and LDL (low-density lipoprotein) cholesterol, testosterone remained independently associated (adjusted OR 2.043 per SD, 95% CI 1.221–3.420, p = 0.007), as did diabetes mellitus (OR 2.60, p = 0.032). Conclusions: Elevated serum testosterone is paradoxically associated with increased prevalence of coronary stenosis in our cohort. These findings from stable, chronic CAD patients may work fundamentally differently from what is observed in acute coronary syndromes, where stress-induced testosterone suppression may confound observed associations.